Abstract Objective To investigate the association between genotype and phenotype of microdeletion and microduplication syndromes (MMSs) and the pathogenesis of pathogenic copy number variations (CNVs). Methods A total of 50 children with MMSs diagnosed by chromosomal microarray analysis (CMA) from June 2013 to September 2015 were enrolled, and the clinical manifestations and features of pathogenic CNVs were analyzed. Results The main clinical manifestations of children with MMSs included mental retardation, developmental delay, short stature, and unusual facies, with the presence of abnormalities in multiple systems. There were 54 pathogenic CNVs in total, consisting of 36 microdeletion segments and 18 microduplication segments, with sizes ranging from 28 kb to 48.5 Mb (mean 13.86 Mb). Pathogenic CNVs often occurred in chromosomes X, 15, and 1. Conclusions The clinical manifestations of MMSs are not specific, and a genotype-first approach can be used for diagnosis. Mode of inheritance, type of recombination (deletion or duplication), size of segment, and functional genes included helps with the interpretation of CNVs of de novo mutations, and in-depth research on rare pathogenesis may become breakthrough points for the identification of new MMSs.
ZHANG Li-Na,MENG Zhe,HE Zhan-Wen et al. Clinical phenotypes and copy number variations in children with microdeletion and microduplication syndromes: an analysis of 50 cases[J]. CJCP, 2016, 18(9): 840-845.
ZHANG Li-Na,MENG Zhe,HE Zhan-Wen et al. Clinical phenotypes and copy number variations in children with microdeletion and microduplication syndromes: an analysis of 50 cases[J]. CJCP, 2016, 18(9): 840-845.
Weise A, Mrasek K, Klein E, et al. Microdeletion and microduplication syndromes[J]. J Histochem Cytochem, 2012, 60(5):346-358.
[2]
Fan YS, Ouyang X, Peng J, et al. Frequent detection of parental consanguinity in children with developmental disorders by a combined CGH and SNP microarray[J]. Mol Cytogenet, 2013, 6(1):38.
[3]
Kaminsky EB, Kaul V, Paschall J, et al. An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities[J]. Genet Med, 2011, 13(9):777-784.
[4]
Coulter ME, Miller DT, Harris DJ, et al. Chromosomal microarray testing influences medical management[J]. Genet Med, 2011, 13(9):770-776.
[5]
Cooper GM, Coe BP, Girirajan S, et al. A copy number variation morbidity map of developmental delay[J]. Nat Genet, 2011, 43(9):838-846.
[6]
Battaglia A, Doccini V, Bernardini L, et al. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features[J]. Eur J Paediatr Neurol, 2013, 17(6):589-599.
[7]
Miller DT, Adam MP, Aradhya S, et al. Consensus statement:chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies[J]. Am J Hum Genet, 2010, 86(5):749-764.
Nevado J, Mergener R, Palomares-Bralo M, et al. New microdeletion and microduplication syndromes:A comprehensive review[J]. Genet Mol Biol, 2014, 37(1 Suppl):210-219.
[11]
Liehr T, Ewers E, Hamid AB, et al. Small supernumerary marker chromosomes and uniparental disomy have a story to tell[J]. J Histochem Cytochem, 2011, 59(9):842-848.
[12]
Turner DJ, Miretti M, Rajan D, et al. Germline rates of de novo meiotic deletions and duplications causing several genomic disorders[J]. Nat Genet, 2008, 40(1):90-95.
[13]
Gazave E, Darré F, Morcillo-Suarez C, et al. Copy number variation analysis in the great apes reveals species-specific patterns of structural variation[J]. Genome Res, 2011, 21(10):1626-1639.
[14]
Mrasek K, Schoder C, Teichmann AC, et al. Global screening and extended nomenclature for 230 aphidicolin-inducible fragile sites, including 61 yet unreported ones[J]. Int J Oncol, 2010, 36(4):929-940.
[15]
Lee JA, Carvalho CM, Lupski JR. A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders[J]. Cell, 2007, 131(7):1235-1247.
[16]
Vissers LE, Stankiewicz P, Yatsenko SA, et al. Complex chromosome 17p rearrangements associated with low-copy repeats in two patients with congenital anomalies[J]. Hum Genet, 2007, 121(6):697-709.
[17]
Marijke Bauters, Hide Van Esch, Michael J. Friez, et al. Nonrecurrent MECP2 duplications mediated by genomic architecture-driven DNA breaks and break-induced replication repair[J]. Genome Res, 2008, 18(6):847-858.
[18]
Miller DT, Adam MP, Aradhya S, et al. Consensus statement:chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies[J]. Am J Hum Genet, 2010, 86(5):749-764.
[19]
Brunetti-Pierri N, Berg JS, Scaglia F, et al. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities[J]. Nat Genet, 2008, 40(12):1466-1471.
[20]
Tsilou E, MacDonald IM. Weill-Marchesani syndrome. GeneReviews[M/OL]. Seattle (WA):University of Washington, Seattle.[2016-04-12].
[21]
Radonic T. Marfan syndrome[J]. Ned Tijdschr Tandheelkd, 2013, 120(12):665-668.
[22]
Liu R, Lei JX, Luo C, et al. Increased EID1 nuclear translocation impairs synaptic plasticity and memory function associated with pathogenesis of Alzheimer's disease[J]. Neurobiol Dis, 2012, 45(3):902-912.
[23]
Park YY, Park KC, Shong M, et al. EID-1 interacts with orphan nuclear receptor SF-1 and represses its transactivation[J]. Mol Cells, 2007, 24(3):372-377.
